PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cardiovascular Research

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CARDIORES.2007.01.010PMID 17320065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet‐activating factor‐induced NF‐κB activation enhances VEGF expression through a decrease in p53 activity

  2006cited by this paper
• Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.

  2005cited by this paper
• B-Raf-dependent expression of vascular endothelial growth factor-A in Kaposi sarcoma-associated herpesvirus-infected human B cells.

  2005influential reference
• Beneficial effects of PPAR-γ ligands in ischemia–reperfusion injury, inflammation and shock

  2005cited by this paper
• Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury.

  2004cited by this paper
• Mitogen Activated Protein kinase signal transduction pathways in the prostate

  2004cited by this paper
• PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats.

  2004cited by this paper
• Therapeutic myocardial angiogenesis with vascular endothelial growth factors

  2004cited by this paper
• Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling

  2004cited by this paper
• Nitric Oxide Production and Regulation of Endothelial Nitric-oxide Synthase Phosphorylation by Prolonged Treatment with Troglitazone

  2004influential reference
• PPAR&agr; Activators Inhibit Vascular Endothelial Growth Factor Receptor-2 Expression by Repressing Sp1-Dependent DNA Binding and Transactivation

  2004cited by this paper
• Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis.

  2004cited by this paper
• Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways.

  2004cited by this paper
• Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator-activated receptors.

  2004cited by this paper
• Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion.

  2004cited by this paper
• Cardiac myofibroblasts isolated from the site of myocardial infarction express endothelin de novo.

  2003cited by this paper
• Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Attenuates Myocardial Ischemia/Reperfusion Injury in a Rat Model

  2003cited by this paper
• Growing and shaping the vascular tree: multiple roles for VEGF

  2003cited by this paper
• Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR.

  2003influential reference
• VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells.

  2002cited by this paper
• Activation of the peroxisome proliferator-activated receptor α protects against myocardial ischaemic injury and improves endothelial vasodilatation

  2002cited by this paper
• Ligands of Peroxisome Proliferator-activated Receptor-γ Block Activation of Pancreatic Stellate Cells*

  2002cited by this paper
• Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.

  2002cited by this paper
• Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis.

  2002cited by this paper
• Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.

  2002cited by this paper
• Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury.

  2002cited by this paper
• Ligands of the peroxisome proliferator‐activated receptors (PPAR‐γ and PPAR‐α) reduce myocardial infarct size

  2002cited by this paper
• Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Inhibition of Cardiac Hypertrophy In Vitro and In Vivo

  2002influential reference
• PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines.

  2002cited by this paper
• Peroxisome proliferator-activated receptors in inflammation control.

  2001cited by this paper
• Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells.

  2001cited by this paper
• Role of vascular endothelial growth factor in regulation of physiological angiogenesis.

  2001influential reference
• Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages.

  2000cited by this paper
• 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway

  2000cited by this paper
• 15-deoxy Δ^ -PGJ2 inhibits multiple steps in the NF-kappaB signaling pathway

  2000cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.

  2000cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Agonists Increase Vascular Endothelial Growth Factor Expression in Human Vascular Smooth Muscle Cells

  2000cited by this paper
• Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in Vivo *

  1999cited by this paper
• Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease.

  1999cited by this paper
• Loss-of-function mutations in PPAR gamma associated with human colon cancer.

  1999cited by this paper
• Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

  1999cited by this paper
• Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates.

  1997cited by this paper
• Myofibroblasts and local angiotensin II in rat cardiac tissue repair.

  1997cited by this paper
• Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts.

  1997cited by this paper
• Cultured myofibroblasts generate angiotensin peptides de novo.

  1997cited by this paper
• Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

  1994cited by this paper
• The myofibroblast in pulmonary fibrosis.

  1983cited by this paper
• J Am Soc Nephrol 13: 2223–2231, 2002 PPAR Agonists Amplify iNOS Expression While Inhibiting NF-�B: Implications for Mesangial Cell Activation by

  year unknowninfluential reference

• A contractile-programmable sensor patch with antibacterial and immunomodulatory properties for infected wound management

  2025cites this paper
• Cardioprotective Effects of SAR Through Attenuating Cardiac-Specific Markers, Inflammatory Markers, Oxidative Stress, and Anxiety in Rats Challenged with 5-Fluorouracil

  2025cites this paper
• The Role of Endothelial L-PGDS in the Pro-Angiogenic and Anti-Inflammatory Effects of Low-Dose Alcohol Consumption

  2024cites this paper
• In vitro hair growth-promoting effects of araliadiol via the p38/PPAR-γ signaling pathway in human hair follicle stem cells and dermal papilla cells

  2024cites this paper
• Effects of swimming before and during pregnancy on placental angiogenesis and perinatal outcome in high-fat diet-fed mice

  2023cites this paper
• Chronic Low-Dose Alcohol Consumption Promotes Cerebral Angiogenesis in Mice

  2021cites this paper
• Antioxidant Properties of Anthocyanins and Their Mechanism of Action in Atherosclerosis.

  2021cites this paper
• PPARs and Angiogenesis—Implications in Pathology

  2020cites this paper
• Protective Effects of Foam Rolling against Inflammation and Notexin Induced Muscle Damage in Rats

  2020cites this paper
• Clofibrate improves myocardial ischemia-induced damage through regulation of renin-angiotensin system and favours a pro-vasodilator profile in left ventricle.

  2020cites this paper
• Mechanical regulation of gene expression in cardiac myocytes and fibroblasts

  2019cites this paper
• Rosiglitazone accelerates wound healing by improving endothelial precursor cell function and angiogenesis in db/db mice

  2019cites this paper
• Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension

  2019cites this paper
• Receptory aktywowane przez proliferatory peroksysomów w procesie nowotworzenia - fakty i kontrowersje

  2018cites this paper
• The Biological Role of Nestin(+)-Cells in Physiological and Pathological Cardiovascular Remodeling

  2018cites this paper
• Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance

  2018cites this paper
• Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis

  2018cites this paper
• Epicatechin as a Therapeutic Strategy to Mitigate the Development of Cardiac Remodeling and Fibrosis

  2017cites this paper
• Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation

  2017cites this paper
• Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis

  2016cites this paper
• Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility

  2016cites this paper
• The Ticking of the Epigenetic Clock: Antipsychotic Drugs in Old Age

  2016cites this paper
• Effects of Bezafibrate on the Survival of Random Skin Flaps in Rats

  2016cites this paper
• Effect of prostaglandin D 2 on VEGF release by nasal polyp fi broblasts

  2016cites this paper
• Bioinformatic and Genomic Approaches to Study Cardiovascular Diseases

  2016cites this paper
• The Role of β-adrenergic Signalling and Natriuretic Peptide Receptors in Cardiac Myofibroblast Proliferation and Differentiation

  2016cites this paper
• Cilostazol Enhances Mobilization of Circulating Endothelial Progenitor Cells and Improves Endothelium-Dependent Function in Patients at High Risk of Cardiovascular Disease

  2016cites this paper
• Effect of prostaglandin D2 on VEGF release by nasal polyp fibroblasts.

  2016cites this paper
• Lanatoside C Promotes Foam Cell Formation and Atherosclerosis

  2016cites this paper
• The Pleiotropic Effects of PPARs on Vascular Cells and Angiogenesis: Implications for Tissue Engineering.

  2016cites this paper
• Eicosapentaenoic acid upregulates VEGF-A through both GPR120 and PPARγ mediated pathways in 3T3-L1 adipocytes.

  2015cites this paper
• Mechanisms of Hyperhomocysteinemia Induced Skeletal Muscle Myopathy after Ischemia in the CBS−/+ Mouse Model

  2015cites this paper
• An experimental study of muscular injury repair in a mouse model of notexin-induced lesion with EPI® technique

  2015cites this paper
• Allogeneic adipose stem cell therapy in acute myocardial infarction

  2014cites this paper
• Impact des ligands de PPARs, et leurs dérivés, sur les cellules cancéreuses coliques humaines : modifications des statuts redox et glycolytique

  2014cites this paper
• The PGE2-EP Receptor Axis in Colorectal Cancer and Angiogenesis

  2014cites this paper
• PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting

  2014cites this paper
• Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury.

  2014cites this paper
• Pre-transplant signal induction for vascularisation in human islets

  2013cites this paper
• Molecular Implications of the PPARs in the Diabetic Eye

  2013cites this paper
• Targeting Wnt signaling to improve wound healing after myocardial infarction.

  2013cites this paper
• Angiogenesis, Arteriogenesis, and Mitochondrial Dysfunction

  2013cites this paper
• UNDERSTANDING THE ROLE OF LIPOCALIN 2 AS AN IMPORTANT REGULATOR OF ENERGY METABOLISM

  2013cites this paper
• The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

  2012cites this paper
• Regulation of human thyroid follicular cell function by inhibition of vascular endothelial growth factor receptor signalling.

  2012cites this paper
• Imbalance of Apoptosis and Cell Proliferation Contributes to the Development and Persistence of Emphysema

  2012cites this paper
• The expression receptor of peroxisome proliferator-activated receptor gamma (PPARγ) mRNA in human aorta compared to left ventricle in patients with coronary artery disease without diabetes

  2012cites this paper
• Angiogenic response of advanced glycation end products (AGEs) involves PPARgamma.

  2012cites this paper
• Pioglitazone Prevents Capillary Rarefaction in Streptozotocin-Diabetic Rats Independently of Glucose Control and Vascular Endothelial Growth Factor Expression

  2012cites this paper
• The Role of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer

  2012cites this paper
• PPARγ agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4/TRIF/IRF3/IP-10 signaling pathway.

  2011cites this paper
• Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease

  2011cites this paper
• Ghrelin inhibits insulin resistance induced by glucotoxicity and lipotoxicity in cardiomyocyte.

  2011cites this paper
• Adipose Tissue-Derived Soluble Fms-Like Tyrosine Kinase 1 Is an Obesity-Relevant Endogenous Paracrine Adipokine

  2011cites this paper
• Up-regulation of peroxisome proliferator-activated receptor gamma in radiation-induced heart injury in rats

  2011cites this paper
• PPARs and angiogenesis.

  2011cites this paper
• Cardiomyocyte PDGFR-beta signaling is an essential component of the mouse cardiac response to load-induced stress.

  2010cites this paper
• Maternal dietary choline deficiency alters angiogenesis in fetal mouse hippocampus

  2010cites this paper
• In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate.

  2010cites this paper
• Thiazolidinediones enhance vascular endothelial growth factor expression and induce cell growth inhibition in non-small-cell lung cancer cells

  2010cites this paper
• GW0742, a High Affinity PPAR-β/δ Agonist Reduces Lung Inflammation Induced by Bleomycin Instillation in Mice

  2010cites this paper
• Methyl 2-Cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a Derivative of Glycyrrhetinic Acid, Functions as a Potent Angiogenesis Inhibitor

  2010cites this paper
• Telmisartan increases the permeability of endothelial cells through zonula occludens-1.

  2009cites this paper
• Cardiac fibroblasts: at the heart of myocardial remodeling.

  2009cites this paper
• Activation of PPARβ/δ inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release

  2009cites this paper
• Nicotinic Acid-Mediated Activation of Both Membrane and Nuclear Receptors towards Therapeutic Glucocorticoid Mimetics for Treating Multiple Sclerosis

  2009cites this paper
• Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis.

  2009cites this paper
• PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR γ‐INDEPENDENT EFFECTS OF THIAZOLIDINEDIONES ON HUMAN CARDIAC MYOFIBROBLAST FUNCTION

  2009influential citation
• Regulation of angiogenesis by oxygen and metabolism.

  2009cites this paper
• Peroxisome proliferator-activated receptors and angiogenesis.

  2009cites this paper
• Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells.

  2009cites this paper
• Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes

  2009cites this paper
• 15-lipoxygenase-1 in the vasculature: expanding roles in angiogenesis.

  2008cites this paper
• PPAR-γ, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches

  2008cites this paper
• The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis.

  2008cites this paper
• Selective Activation of Peroxisome Proliferator–Activated Receptor (PPAR)α and PPARγ Induces Neoangiogenesis Through a Vascular Endothelial Growth Factor–Dependent Mechanism

  2008cites this paper
• Keratinocyte-Derived Vascular Endothelial Growth Factor Biosynthesis Represents a Pleiotropic Side Effect of Peroxisome Proliferator-Activated Receptor-γ Agonist Troglitazone but Not Rosiglitazone and Involves Activation of p38 Mitogen-Activated Protein Kinase: Implications for Diabetes-Impaired Ski

  2008cites this paper
• The Role of PPARs in the Endothelium: Implications for Cancer Therapy

  2008cites this paper
• Peroxisome proliferator-activated receptor γ expression correlates with tumor angiogenesis in human hepatocellular carcinoma

  2008cites this paper
• PPAR-gamma expression in animals subjected to volume overload and chronic Urotensin II administration.

  2008cites this paper
• ReviewArticle The Role of PPARs in the Endothelium: Implications for Cancer Therapy

  2008cites this paper
• ReviewArticle PPARγ and MEK Interactions in Cancer

  2008cites this paper
• Expanding Roles in Angiogenesis

  2008cites this paper
• PPARγ and Agonists against Cancer: Rational Design of Complementation Treatments

  2008cites this paper
• Keratinocyte-derived VEGF biosynthesis represents a pleiotropic side effect of PPAR γ agonist troglitazone but not rosiglitazone and involves activation of p38 MAPK: implications for diabetes-impaired skin repair

  2008cites this paper
• Selective Activation of PPAR α and PPAR γ Induces Neoangiogenesis through a VEGF-dependent Mechanism

  2008cites this paper
• PPARγ and MEK Interactions in Cancer

  2008cites this paper
• PPAR Action in Human Placental Development and Pregnancy and Its Complications

  2007cites this paper
• PPAR-γ in the Cardiovascular System

  2007cites this paper
• Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis

  2007cites this paper
• Review Article Peroxisome Proliferator-activated Receptor-γ Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer

  year unknowncites this paper